Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Narcan maker says over-the-counter nasal spray fast-tracked by FDA

Por: The Hill Health December 07, 2022

thumbnail

Emergent BioSolutions Inc., the maker of narcotic overdose treatment Narcan, that the Food and Drug Administration (FDA) has accepted its application to grant priority review of its overdose nasal spray as an over-the-counter (OTC) product. “The application has been granted Priority Review by the FDA and, if approved, would be the first 4 mg naloxone nasal spray available OTC in the U.S. The Prescription Drug User Fee Act goal date is March... + full article



Similar News

Health Care — Review recommends changes for FDA food program

The Hill USA Health December 08, 2022

thumbnailLeave it to Ticketmaster to unite Republicans and Democrats: Bipartisan members of the House Energy and Commerce Committee want a briefing about the company’s Taylor Swift debacle.   Today in health, lawmakers are on the verge of getting rid of the Pentagon’s COVID-19... + más

ALS drug wins FDA approval despite questionable data | ABC News

ALS drug wins FDA approval despite questionable data | WPLG Local 10


Narcan could be required at California schools after youth fentanyl overdoses

Los Angeles Times USA Politics December 08, 2022

thumbnailFollowing spates of fentanyl overdoses among students, California public schools could be required to provide Narcan on campuses — a nasal spray that can reverse deadly effects of opioids. The proposal is part of legislation introduced by both Democratic and Republican state... + más

California programs are waiting weeks for free Narcan to prevent overdose deaths | Los Angeles Times

What is rainbow fentanyl? Colorful pills drive new warnings about deadliest drug in the US | CNN


Narcan maker says anti-opioid nasal spray will soon be available over the counter

CBS News USA Health December 07, 2022

thumbnailAmericans may soon no longer need a prescription to buy a life-saving nasal spray for people who overdose on opioids.Emergent BioSolutions on Tuesday said the Food and Drug Administration has fast-tracked its application for an over-the-counter version of Narcan, a nasal-spray... + más

California programs are waiting weeks for free Narcan to prevent overdose deaths | Los Angeles Times

Narcan maker says over-the-counter nasal spray fast-tracked by FDA | The Hill


FDA opens door to make opioid overdose antidote available over the counter

NBC News USA Nation November 16, 2022

thumbnailThe Food and Drug Administration is pushing for drugmakers to apply for over-the-counter approval for naloxone, the opioid overdose antidote. In a notice published online Tuesday, the agency said that it “strongly encourages” naloxone makers to contact the FDA “as early as... + más

Why Overdose Deaths Have Increased | Time

US overdose deaths may be peaking, but experts are wary | WPLG Local 10


California programs are waiting weeks for free Narcan to prevent overdose deaths

Los Angeles Times USA Nation November 14, 2022

thumbnailAfter losing her son Luke to an overdose, Sheila Scott has been trying to get revenge on death, she said. Scott founded the Lukelove Foundation and has been teaching families how to use Narcan, a nasal spray containing naloxone that can reverse the deadly effects of opioids. If... + más

Going to EDC? Grab a dose of Narcan | Orlando Sentinel

US overdose deaths may be peaking, but experts are wary | ABC News


Without a nasal vaccine, the U.S. edge in fighting Covid is on the line

Politico USA Health October 15, 2022

thumbnailBiden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más

Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica

Nasal COVID vaccine fails to offer desired protection in testing | The Hill


Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab

Ars Technica USA Science October 12, 2022

thumbnailNavigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 12, 2022 5:17 pm UTC / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake... + más

Nasal COVID vaccine fails to offer desired protection in testing | The Hill

Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes



About iurex | Privacy Policy | Disclaimer |